Hypotensive Treatment of Glaucoma — Minimally Invasive Surgery. Literature review
https://doi.org/10.18008/1816-5095-2022-1-5-14
Abstract
Glaucoma continues to be the disease leading to vision loss and blindness. Currently, various treatment options are offered for persistent compensation of intraocular pressure, as the main cause of the glaucoma optic neuropathy development. In the last decade, technologies for minimally invasive glaucoma surgery have been actively developing, presenting for patients a good alternative to drug antihypertensive therapy and traditional surgical approaches with minimal trauma, efficiency and quick rehabilitation. The review briefly discusses the various devices and implantation methods used in minimally invasive glaucoma surgery, with examples of studies showing long-term clinical results.
About the Authors
M. A. Melnik
Medical Research and Education Center of the Moscow State University named after M.V. Lomonosov
Russian Federation
Russian Federation
Melnik Mariya A., ophthalmologist of the ophthalmology department
Lomonosovskiy ave.. 27/10, Moscow, 119234
V. R. Mamikonyan
Medical Research and Education Center of the Moscow State University named after M.V. Lomonosov
Russian Federation
Russian Federation
Mamikonyn Vardan R., MD, Professor, head of the of the ophthalmology department
Lomonosovskiy ave., 27/10, Moscow, 119234
O. A. Shmeleva-Kenoufi
Medical Research and Education Center of the Moscow State University named after M.V. Lomonosov
Russian Federation
Russian Federation
Shmeleva-Kenoufi Olga A., PhD, ophthalmologist of the ophthalmology department
Lomonosovskiy ave., 27/10, Moscow, 119234
A. I. Mukha
Medical Research and Education Center of the Moscow State University named after M.V. Lomonosov
Russian Federation
Russian Federation
Mukha Alexander I., MD, ophthalmologist of the consultative and diagnostic department
Lomonosovskiy ave., 27/10, Moscow, 119234
References
1. Petrov S.Yu., Vostrukhin S.V., Aslamazov A.E., Sherstneva L.V. Modern methods of minimally invasive glaucoma surgery. Annals of Ophthalmology = Vestnik oftal’mologii. 2016;3:96–102 (In Russ.). DOI: 10.17116/oftalma2016132396-102
2. Mamikonyan V.R., Fisenko N.V. Glaucoma surgery: from traditional filtration techniques to modern principles of bioengineering. Annals of Ophthalmology = Vestnik oftal’mologii. 2018;5(1):111–117 (In Russ.). DOI: 10.17116/oftalma2018134051111
3. Waisbourd M., Katz L.J. Selective laser trabeculoplasty as a first-line therapy: a review. Can. J. Ophthalmol. 2014;49(6):519–522. DOI: 10.1016/j.jcjo.2014.10.003
4. Anisimov S.I., Anisimova S.Y., Arutyunyan L.L., Voznyuk A.P., Anisimova N.S. Modern approaches to surgical treatment of combined pathology of glaucoma and cataract. National Journal glaucoma = Natsional’nyi zhurnal glaukoma. 2019;18(4):86–95 (In Russ.). DOI: 10.25700/NJG.2019.04.07
5. Saheb H., Ahmed I.I. Microinvasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol. 2012;23(2):96–104. DOI: 10.1097/ICU.0b013e32834ff1e7
6. Bovee C.E., Pasquale L.R. Evolving surgical interventions in the treatment of glaucoma. Semin Ophthalmol. 2017;32:91–95. DOI: 10.1080/08820538.2016.1228393
7. Francis B.A., Akil H., Bert B.B. Ab interno Schlemm’s Canal surgery. Dev Ophthalmol. 2017;59:127–146. DOI: 10.1159/000458492
8. Malvankar-Mehta M.S., Iordanous Y., Chen Y.N. iStent with phacoemulsification versus phacoemulsification alone for patients with glaucoma and cataract: a metaanalysis. PLoS One. 2015;10(7):1–23. DOI: 10.1371/journal.pone.0131770
9. Fernandez-Barrientos Y., Garcia-Feijoo J., Martinez-de-la-Casa J.M., Pablo L.E., Fernandez-Perez C., Garcia Sanchez J. Fluorophotometric study of the effect of the glaukos trabecular microbypass stent on aqueous humor dynamics. Investigative ophthalmology & visual science. 2010;51(7):3327–3332. DOI: 10.1167/iovs.09-3972
10. Hunter K.S., Fjield T., Heitzmann H., Shandas R., Kahook M.Y. Characterization of micro-invasive trabecular bypass stents by ex vivo perfusion and computational flow modeling. Clinical ophthalmology. 2014;8:499–506. DOI: 10.2147/OPTH.S56245
11. Belovay G.W., Naqi A., Chan B.J., Rateb M., Ahmed I.I. Using multiple trabecular micro-bypass stents in cataract patients to treat open-angle glaucoma. Journal of cataract and refractive surgery. 2012;38(11):1911–1917. DOI: 10.1016/j.jcrs.2012.07.017
12. Fea A.M. Phacoemulsification versus phacoemulsification with micro-bypass stent implantation in primary open-angle glaucoma: randomized doublemasked clinical trial. J Cataract Refract Surg. 2010;36:407–412. DOI: 10.1016/j.jcrs.2009.10.031
13. Samuelson T.W., Katz L.J., Wells J.M., Duh Y.J., Giamporcaro J.E.; US iStent Study Group. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology. 2011;118(3):459–467. DOI: 10.1016/j.ophtha.2010.07.007
14. Craven E.R., Katz L.J., Wells J.M., Giamporcaro J.E.; iStent Study Group. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-tomoderate open-angle glaucoma and cataract: two-year follow-up. J Cataract Refract Surg. 2012;38(8):1339–1345. DOI: 10.1016/j.jcrs.2012.03.025
15. Bahler C.K., Hann C.R., Fjield T., Haffner D., Heitzmann H., Fautsch M.P. Second-generation trabecular meshwork bypass stent (iStent inject) increases outflow facility in cultured human anterior segments. American journal of ophthalmology. 2012;153(6):1206–1213. DOI: 10.1016/j.ajo.2011.12.017
16. Voskanyan L., Garcia-Feijoo J., Belda J.I., Fea A., Junemann A., Baudouin C., Synergy Study G. Prospective, unmasked evaluation of the iStent(R) inject system for open-angle glaucoma: synergy trial. Advances in therapy. 2014;31(2):189–201. DOI: 10.1007/s12325-014-0095-y
17. Arriola-Villalobos P., Martinez-de-la-Casa J.M., Diaz-Valle D., Morales-Fernandez L., Fernandez-Perez C., Garcia-Feijoo J. Glaukos iStent inject® Trabecular Micro-Bypass Implantation Associated with Cataract Surgery in Patients with Coexisting Cataract and Open-Angle Glaucoma or Ocular Hypertension: A Long-Term Study. Journal of Ophthalmology. 2016;1056573:7. DOI: 10.1155/2016/1056573
18. Zhou J., Smedley G.T. A trabecular bypass flow hypothesis. J Glaucoma. 2005;14:74–83. DOI: 10.1097/01.ijg.0000146360.07540.ml
19. Bahler C.K., Smedley G.T., Zhou J., Johnson D.H. Trabecular bypass stents decrease intraocular pressure in cultured human anterior segments. Am J Ophthalmol. 2004;138:988–994. DOI: 10.1016/j.ajo.2004.07.035
20. Samuelson T.W. A cataract surgeon’s guide to iStent inject W. Euro Times. Supplement December 2019/January 2020.
21. Vinod K., Gedde S.J. Clinical investigation of new glaucoma procedures. Curr Opin Ophthalmol. 2017;28(2):187–193. DOI: 10.1097/icu.0000000000000336
22. Myers J.S., Masood I., Hornbeak D.M. Prospective evaluation of two iStent® trabecular stents, one iStent SUPRA® suprachoroidal stent, and postoperative prostaglandin in refractory glaucoma: 4-year outcomes. Adv Ther. 2018;35(3):395–407. DOI: 10.1007/s12325-018-0666-4
23. Sameh Mosaed. Minimally invasive glaucoma surgery and CyPass Micro-Stent — a new era in glaucoma surgery. US Ophthalmic Review. 2017;10(1):39–41. DOI: 10.17925/USOR.2017.10.01.39
24. Hoeh H., Ahmed I.I., Grisanti S., Grisanti S., Grabner G., Nguyen Q.H., Rau M., Yoo S., Ianchulev T. Early postoperative safety and surgical outcomes after implantation of a suprachoroidal micro-stent for the treatment of open-angle glaucoma concomitant with cataract surgery. J Cataract Refract Surg. 2013;39(3):431–437. DOI: 10.1016/j.jcrs.2012.10.040
25. Höeh H., Grisanti S., Grisanti S., Rau M., Ianchulev S. Two-year clinical experience with the CyPass micro-stent: safety and surgical outcomes of a novel supraciliary micro-stent. Klin Monatsbl Augenheilkd. 2014;231(4):377–381. DOI: 10.1055/s-0034-1368214
26. García-Feijoó J., Rau M., Grisanti S. Supraciliary micro-stent implantation for open angle glaucoma failing topical therapy: 1 year results of a multicenter study. Am J Ophthalmol. 2015;159:1075–1081. DOI: 10.1016/j.ajo.2015.02.018
27. Vold S., Ahmed I.I., Craven E.R. Two-year COMPASS trial results: supraciliary microstenting with phacoemulsification in patients with open-angle glaucoma and cataracts. Ophthalmology. 2016;123(10):2103–2112. DOI: 10.1016/j.ophtha.2016.06.032
28. Reiss G., Clifford B., Vold S., He J., Hamilton C., Dickerson J., Lane S. Safety and Effectiveness of CyPass Supraciliary Micro-Stent in Primary Open-Angle Glaucoma: 5-Year Results from the COMPASS XT Study. Am J Ophthalmol. 2019;208:219–225. DOI: 10.1016/j.ajo.2019.07.015
29. Denis P., Hirneiß C., Durr GM., Reddy KP., Kamarthy A., Calvo E., Hussain Z., Ahmed IK. Two-year outcomes of the MINIject drainage system for uncontrolled glaucoma from the STAR-I first-in-human trial. Br J Ophthalmol. 2020;0:1–6. DOI: 10.1136/bjophthalmol-2020-316888
30. Pfeiffer N. A randomized trial of a Schlemm’s canal microstent with phacoemulsification for reducing intraocular pressure in open-angle glaucoma. Ophthalmology. 2015;122(7):1283–1293. DOI: 10.1016/j.ophtha.2015.03.031
31. Grierson I., Saheb H., Kahook M.Y., Johnstone M.A., Ahmed I.I., Schieber A.T., Toris C.B. A Novel Schlemm’s canal scaffold: histologic observations. J Glaucoma. 2015;24(6):460–468. DOI: 10.1097/IJG.0000000000000012
32. Gandolfi S.A. Comparison of surgical outcomes between canaloplasty and Schlemm’s canal scaffold at 24 Months’ follow-up. J Ophthalmol. 2016;2016:3410469. DOI: 10.1155/2016/3410469
33. Bill A. Some aspects of aqueous humour drainage. Eye (Lond). 1993;7(Pt 1):14–19. DOI : 10.1038/eye.1993.4
34. Fellman R.L., Grover D.S. Episcleral venous fluid wave: intraoperative evidence for patency of the conventional outflow system. J Glaucoma. 2014;23(6):347–350. DOI: 10.1097/IJG.0b013e31827a06d8
35. Grieshaber M.C. Clinical evaluation of the aqueous outflow system in primary open-angle glaucoma for canaloplasty. Invest Ophthalmol Vis Sci. 2010;51(3):1498–1504. DOI: 10.1167/iovs.09-4327
36. Kagemann L. Identification and assessment of Schlemm’s canal by spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2010;51(8):4054–4059. DOI: 10.1167/iovs.09-4559
37. Gulati V. A novel 8-mm Schlemm’s canal scaffold reduces outflow resistance in a human anterior segment perfusion model. Invest Ophthalmol Vis Sci. 2013;54(3):1698–1704. DOI: 10.1167/iovs.12-11373
38. Pfeiffer N. A randomized trial of a Schlemm’s canal microstent with phacoemulsification for reducing intraocular pressure in open-angle glaucoma. Ophthalmology. 2015;122(7):1283–1293. DOI: 10.1016/j.ophtha.2015.03.031
39. Samuelson T. A Schlemm Canal Microstent for Intraocular Pressure Reduction in Primary Open-Angle Glaucoma and Cataract: The HORIZON Study. Ophthalmology. 2019 Jan;126(1):29–37. DOI: 10.1016/j.ophtha.2018.05.012
40. Kaplowitz K., Schuman J.S., Loewen N.A. Techniques and outcomes of minimally invasive trabecular ablation and bypass surgery. Br J Ophthalmol. 2014;98:579–585. DOI: 10.1136/bjophthalmol-2013-304256
41. Akil H., Chopra V., Huang A.S., Swamy R., Francis B.A. Short-term clinical results of ab interno trabeculotomy using the Trabectome with or without cataract surgery for open-angle glaucoma patients of high intraocular pressure. J Ophthalmol. 2017;2017:8248710. DOI: 10.1155/2017/8248710
42. Gonnermann J., Bertelmann E., Pahlitzsch M., Maier-Wenzel A.B., Torun N., Klamann M.K. Contralateral eye comparison study in MICS & MIGS: Trabectome(R) vs. iStent inject(R). Graefes Arch Clin Exp Ophthalmol. 2017;255(2):359–365. DOI: 10.1007/s00417-016-3514-8
43. Khan M., Saheb H., Neelakantan A., Fellman R., Vest Z., Harasymowycz P. Efficacy and safety of combined cataract surgery with 2 trabecular microbypass stents versus ab interno trabeculotomy. J Cataract Refract Surg. 2015;41(8):1716–1724. DOI: 10.1016/j.jcrs.2014.12.061
44. Mizoguchi T., Nishigaki S., Sato T., Wakiyama H., Ogino N. Clinical results of Trabectome surgery for open-angle glaucoma. Clin Ophthalmol. 2015;9:1889–1894. DOI: 10.2147/OPTH.S83958
45. Oterendorp C., Bahlmann D. Kahook Dual Blade: An instrument for microincisional trabecular meshwork surgery. Ophthalmologe. 2019;116(6):580–584. DOI: 10.1007/s00347-018-0844-4
46. Seibold L., Soohoo J., Ammar D., Kahook M. Preclinical investigation of ab interno trabeculectomy using a novel dual-blade device. Am J Ophthalmol. 2013;155(3):524–529. DOI: 10.1016/j.ajo.2012.09.023
47. Sieck E., Epstein R., Kennedy J., SooHoo J., Pantcheva M., Patnaik J., Wagner B., Lynch A., Kahook M., Seibold L. Outcomes of Kahook Dual Blade Goniotomy with and without Phacoemulsification Cataract Extraction. Ophthalmol Glaucoma. 2018;1(1):75–81. DOI: 10.1016/j.ogla.2018.06.006
48. Dorairaj S., Kahook M., Williamson B., Seibold L., ElMallah M., Singh I. A multicenter retrospective comparison of goniotomy versus trabecular bypass device implantation in glaucoma patients undergoing cataract extraction. Clin Ophthalmol. 2018;12:791–797. DOI: 10.2147/OPTH.S158403
49. Kornmann H., Fellman R., Feuer W., Butler M., Godfrey D., Smith O., Emanuel M., Grover D. Early Results of Goniotomy with the Kahook Dual Blade, a Novel Device for the Treatment of Glaucoma. Clin Ophthalmol. 2019;13:2369–2376. DOI: 10.2147/OPTH.S224643
50. Chen D., Sng C. Safety and Efficacy of Microinvasive Glaucoma Surgery. Hindawi Journal of Ophthalmology. J Ophthalmol. 2017;2017:3182935. DOI: 10,1155/2017/3182935
51. Hirabayashi M., Lee D., King J., Thomsen S., An J. Comparison Of Surgical Outcomes Of 360° Circumferential Trabeculotomy Versus Sectoral Excisional Goniotomy With The Kahook Dual Blade At 6 Months. Clin Ophthalmol. 2019;13:2017–2024. DOI: 10.2147/OPTH.S208468
52. Grover D., Godfrey D., Smith O., Feuer W., Oca I., Fellman R. Gonioscopy-assisted transluminal trabeculotomy, ab interno trabeculotomy: technique report and preliminary results. Ophthalmology. 2014;121(4):855–861. DOI: 10.1016/j.ophtha.2013.11.001
53. Wilmsmeyer S., Philippin H., Funk J. Excimer laser trabeculotomy: a new, minimally invasive procedure for patients with glaucoma. Graefes Arch Clin Exp Ophthalmol. 2006;244(6):670–676. DOI: 10.1007/s00417-005-0136-y
54. Babighian S., Caretti L., Tavolato M., Cian R., Galan A. Excimer laser trabeculotomy vs 180 degrees selective laser trabeculoplasty in primary open-angle glaucoma. A 2-year randomized, controlled trial. Eye (Lond). 2010;24(4):632–638. DOI: 10.1038/eye.2009.172
55. Lewis R. Ab interno approach to the subconjunctival space using a collagen glaucoma stent. J Cataract Refract Surg. 2014;40(8):1301–1306. DOI: 10.1016/j.jcrs.2014.01.032
56. Sheybani A., Reitsamer H., Ahmed I. Fluid Dynamics of a Novel Micro-Fistula Implant for the Surgical Treatment of Glaucoma. IOVS. 2015;56(8):4789–4795. DOI: 10.1167/iovs.15-16625
57. Perez-Torregrosa V., Olate-Perez A., Cerda-Ibanez M. Combined phacoemulsification and XEN45 surgery from a temporal approach and 2 incisions. Arch Soc Esp Oftalmol. 2016;91(9):415–421. DOI: 10.1016/j.oftal.2016.02.006
58. Matlach J., Dhillon C., Hain J., Schlunck G., Grehn F., Klink T. Trabeculectomy versus canaloplasty (TVC study) in the treatment of patients with open-angle glaucoma: a prospective randomized clinical trial. Acta Ophthalmol. 2015;93(8):753–761. DOI: 10.1111/aos.12722
59. Grieshaber M., Pienaar A., Olivier J., Stegmann R. Comparing two tensioning suture sizes for 360 degrees viscocanalostomy (canaloplasty): a randomised controlled trial. Eye (Lond). 2010;24(7):1220–1226. DOI: 10.1038/eye.2009.317
60. Gallardo M., Supnet R., Ahmed I. Circumferential viscodilation of Schlemm’s canal for open-angle glaucoma: ab-interno vs ab-externo canaloplasty with tensioning suture. Clin Ophthalmol. 2018;12:2493–2498. DOI: 10.2147/OPTH.S178962
61. Khaimi M.A. Ab interno canaloplasty. Glaucoma Today. 2015;13:13–15.
62. Tracer N., Dickerson J., Radcliffe N. Circumferential Viscodilation Ab Interno Combined with Phacoemulsification for Treatment of Open-Angle Glaucoma: 12-Month Outcomes. Clin Ophthalmol. 2020;14:1357–1364. DOI: 10.2147/OPTH.S252965
63. Grieshaber M. Stegmann Canal Expander for canaloplasty: A novel technique. Eur J Ophthalmol. 2018;28(4):472–478. DOI: 10.1177/1120672117753699
64. Stewart R., Diamond J., Ashmore E., Ayyala R. Complications following Ex-PRESS glaucoma shunt implantation. Am. J. Ophthalmol. 2005;140(2):340е1–340e2. DOI: 10.1016/j.ajo.2005.02.033
65. Nicolai M., Franceschi A., Pelliccioni P., Pirani V., Mariotti C. EX-PRESS Glaucoma Filtration Device: Management of Complications. Vision (Basel). 2020;4(3):39. DOI: 10.3390/vision4030039
66. Gallego-Pinazo R., Lopez-Sanchez E., Marin-Montiel J. Postoperative outcomes after combined glaucoma surgery. Comparison of ex-press miniature implant with standard trabeculectomy. Archivos de la Sociedad Espanola de Oftalmologia. 2009;84(6):293–297. DOI: 10.4321/s0365-66912009000600004
67. Lankaranian D., Razeghinejad M., Prasad A., Fakhraie G., Freitas D.,Ichhpujani P., Moster M. Intermediate-term results of the Ex-PRESS miniature glaucoma implant under a scleral flap in previously operated eyes. Clinical & experimental ophthalmology. 2011;39(5):421–428. DOI: 10.1111/j.1442-9071.2010.02481.x
68. Beckers H., Aptel F., Webers C., Bluwol E., Martínez-de-la-Casa J., García-Feijoó J., Lachkar Y., Méndez-Hernández C., Riss I., Shao H., Pinchuk L., Angeles R., Sadruddin O., Shaarawy T. Safety and Effectiveness of the PRESERFLO ® MicroShunt in Primary Open-Angle Glaucoma: Results from a 2-Year Multicenter Study. Ophthalmol Glaucoma. 2021;S2589-4196(21)00179-4. DOI: 10.1016/j.ogla.2021.07.008
69. Scheres L., Kujovic-Aleksov S., Ramdas W., Crom R., Roelofs L., Berendschot T., Webers C., Beckers H. XEN ® Gel Stent compared to PRESERFLO™ MicroShunt implantation for primary open-angle glaucoma: two-year results. Acta Ophthalmol. 2021;99(3):e433–e440. DOI: 10.1111/aos.14602
70. Pillunat K., Herber R., Haase M., Jamke M., Jasper C., Pillunat L. PRESERFLO™ MicroShunt versus trabeculectomy: first results on efficacy and safety. Acta Ophthalmol. 2021 Jul. DOI: 10.1111/aos.14968
71. Melamed S., Simon G., Goldenfel M., Simon G. Efficacy and safety of gold micro shunt implantation to the supraciliary space in patients with glaucoma: a pilot study. Arch Ophthalmol. 2009;127(3):264–269. DOI: 10.1001/archophthalmol.2008.611
72. Gigon A., Shaarawy T. The Suprachoroidal Route in Glaucoma Surgery. Journal of Current Glaucoma Practice. 2016;10(1):13–20. DOI: 10.5005/jp-journals-10008-1197
73. König S., Hirnei C. STARflo — a suprachoroidal drainage implant in glaucoma surgery. Ophthalmologe. 2018;115(8):670–675. DOI: 10.1007/s00347-017-0565-0
74. Pourjavan S., Collignon N., De Groot V. STARfloTM Glaucoma Implant: 12 month clinical results. Acta Ophthalmologica (Copenh). 2013;91. DOI: 10.1111/j.1755-3768.2013.3723.x
75. Fili S., Wölfelschneider P., Kohlhaas M. The STARflo glaucoma implant: preliminary 12 months results. Graefes Arch Clin Exp Ophthalmol. 2018;256(4):773–781. DOI: 10.1007/s00417-018-3916-x
Review
For citations:
Melnik M.A., Mamikonyan V.R., Shmeleva-Kenoufi O.A., Mukha A.I. Hypotensive Treatment of Glaucoma — Minimally Invasive Surgery. Literature review. Ophthalmology in Russia. 2022;19(1):5-14. (In Russ.) https://doi.org/10.18008/1816-5095-2022-1-5-14
Views:
750
Email this article 